The application of CAR-T cell therapy in hematological malignancies: advantages and challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The application of CAR-T cell therapy in hematological malignancies: advantages and challenges

Published:2018-07 Issue:4 Volume:8 Page:539-551
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Zhao Zijun,Chen Yu,Francisco Ngiambudulu M.,Zhang Yuanqing,Wu Minhao

Funder

National Natural Science Foundation of China

Guangdong Natural Science Fund for Distinguished Young Scholars

Guangzhou Pearl River New Star Program

Guangdong Innovative Research Team Program

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference145 articles.

1. T-cell-based immunotherapy: adoptive cell transfer and checkpoint inhibition;Houot;Cancer Immunol Res,2015

2. Chimeric antigen receptor-and TCR-modified T cells enter main street and wall street;Barrett;J Immunol,2015

3. Adoptive immunotherapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors;Fujiwara;Pharmaceuticals,2014

4. Antigen-specific T-cell activation independently of the MHC: chimeric antigen receptor-redirected T cells;Chmielewski;Front Immunol,2013

5. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity;Gross;Proc Natl Acad Sci U S A,1989

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-gen oncology: the role of CAR-T cells against ocular lymphoma and myeloma;Eye;2024-09-12

2. Current Insights into CAR T-Cell-Based Therapies for Myelodysplastic Syndrome;Pharmaceutical Research;2024-08-26

3. Advances in Melanoma: From Genetic Insights to Therapeutic Innovations;Biomedicines;2024-08-14

4. The Development in the Regenerative Medicine Industry: Analysis on Global Technology Trends and Local Academic-industry Cooperation Modes;2024 Portland International Conference on Management of Engineering and Technology (PICMET);2024-08-04

5. Lipid nanoparticle-based mRNA vaccines: a new frontier in precision oncology;Precision Clinical Medicine;2024-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3